Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1997-12-24
2000-04-25
Houteman, Scott W.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 235, 435 6, C07H 2104
Patent
active
060545755
ABSTRACT:
Nucleic acids comprising the RNA component of a mammalian telomerase are useful as pharmaceutical, therapeutic, and diagnostic reagents.
REFERENCES:
patent: 5270201 (1993-12-01), Richards et al.
Mehle et al., "Telomere shortening in renal cell carcinoma," Cnacer Research, 54(1) 236-41, Jan. 1994.
Blackburn (1991), Structure and function of telomeres, Nature 350:569-573.
Blackburn (1992), Telomerases, Ann. Rev. Biochem. 61:113-129.
Blackburn et al. (1989), Recognition and elongation of telomeres by telomerase, Genome 31:553-560.
Counter et al. (1992), Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity, EMBO J. 11(5) : 1921-1929.
Czech (Nov. 25, 1988), Ribozymes and their medical implications, JAMA 260(20) : 3030-3034.
Eck and Nabel (1991), Antisense oligonucleotides for therapeutic intervention, Current Opinions Biotechnology 2:897-904.
Greider (Sep. 1991), Teleomerase is processive, Mol. Cell. Bio. 11:4572-4580.
Greider and Blackburn (Dec. 24, 1987), The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity, cell 51:887-898.
Greider and Blackburn (Jan. 26, 1989), A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis, Nature 337(6205):331-337.
Harley et al. (May 31, 1990), Telomeres shorten during ageing of human fibroblasts, Nature 345:458-460.
Harley et al. (1991), Telomere loss: Mitotic clock or genetic time bomb? Mut. Res. 256:271-282.
Morin (Nov. 3, 1989), The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG Repeats, Cell, 59:521-529.
Morin (Oct. 8, 1991), Recognition of a chromosome truncation site associated with alpha-thalassaemia by human telomerase, Nature 353:454-456.
Romero and Blackburn (Oct. 18, 1991), A conserved secondary structure for telomerase RNA, Cell 67:343-353.
Shippen-Lentz and Blackburn (Feb. 2, 1990), Functional evidence for an RNA template in telomerase, Science 247:546-552.
Yu et al, (Mar. 8, 1990), In vitro alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs Nature 344:126-132.
Yu and Blackburn (Nov. 15, 1991), Developmentally programmed healing of chromosomes by telomerase in tetrahymena, Cell 67: 823-832.
Zahler et al. (Apr. 25, 1991), Inhibition of telomerase by G-quartet DNA structures, Nature 350:718-720.
Lingner et al. (1984), Telomerase RNAs of different ciliates have a common secondary structure and a permuted template, Gen and Development 8:1989-1998.
Singer and Gottschling (1994), TLC1: Template RNA Component of Saccharomyces cerevislae Telomerase, Science 266:404-409.
J. Rennie (1994) Scientific American, Jul. pp. 14-16, "Immortal's Enzyme".
B. Rensberger Washington Post, Apr. 12, 1994, pp. A1, A12, Cancer's Immortality May Depend on Enzyme.
Counter et al. (1994) PNAS 91:2900-2904. Telomerase activity in human ovarian carcinoma.
P. Nilsson et al. (1994) Oncogene 9:3043-3048, Telomerase activity in vivo in human malignant hematopoietic cells.
C.W. Greider (1993) Cold Spring Harbor Symposia on Quantitative Biology, vol. LVIII, Cold Spring Harbor Laboratory, NY. Telomerase and Telomere-length Regulation: Lessons from Small Eukaryotes to Mammals.
E.H. Blackburn (1991) TIBS 16:378-381 Telomeres.
Grant Abstracts: Elizabeth Blackburn--5R01 GM 32565-11; 5P30 ES01896-15UB: 9024: 5R37 GM26259-16.
Carol Greider--5R01 RG09383-03; 5R01GM43080-04.
N. Kim et al. (1994) Science 266:2011-2014. Specific Association of Human Telomerase Activity with Activity with Immortal Cells and Cancer.
Prowse et al. (1993) Proc. Nat. Acad. Sci., USA,90: 1493.
J. Feng et al. (1995) Science 269:1236-1241. The RNA Component of Human Telomerase.
Zhao et al., Cloning And Charactrization of Human and Mouse Telomerase RNA Gene Promoter Su.quence; Oncogena 16: 1345-1350 (1998).
Andrews William H.
Feng Junli
Funk Walter
Villeponteau Bryant
Collins Amy L.
Geron Corporation
Houteman Scott W.
Kaster Kevin R.
Parent Annette S.
LandOfFree
Mammalian telomerase RNA gene promoter does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mammalian telomerase RNA gene promoter, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mammalian telomerase RNA gene promoter will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-994383